Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Telik's TLK-286 completes phase I evaluation

Feb. 23, 2001

Spanish research institute discovers new bafilomycins in marine microbe

Feb. 22, 2001

Cell Pathways presents series of apoptosis-inducing antineoplastic agents

Feb. 22, 2001

Panacea enters collaborative agreement with MIT for anticancer antibodies

Feb. 22, 2001

New research program for CRL-5861 in cancer

Feb. 22, 2001

BioNumerik partners with Asta Medica for oncology drug development

Feb. 22, 2001

Hollow fiber model used to study in vitro cytotoxic activity of CHS-828

Feb. 22, 2001

FeRx initiates phase I/II trial of MTC-DOX for metastatic liver cancer

Feb. 22, 2001

Preclinical data support clinical development of BN-80915, a lead homocamptothecin

Feb. 22, 2001

Hybrigenics and Servier to identify new targets for anticancer drugs

Feb. 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...